Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imiquimod - Its role in the treatment of cutaneous malignancies
AdityaKumar Bubna
Indian Journal of Pharmacology (2015) Vol. 47, Iss. 4, pp. 354-354
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
Tianhao Duan, Yang Du, Changsheng Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 491
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 260
Promising Schiff bases in antiviral drug design and discovery
Shikha Kaushik, Sarvesh Paliwal, Malliga R. Iyer, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 6, pp. 1063-1076
Open Access | Times Cited: 60
Ultraviolet Radiation Biological and Medical Implications
Tarek Al-Sadek, Nabiha Yusuf
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 1924-1942
Open Access | Times Cited: 16
TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings
Maryam A. Shetab Boushehri, Alf Lamprecht
Molecular Pharmaceutics (2018) Vol. 15, Iss. 11, pp. 4777-4800
Closed Access | Times Cited: 135
Topical treatments for skin cancer
Jason K. Cullen, Jacinta L. Simmons, Peter G. Parsons, et al.
Advanced Drug Delivery Reviews (2019) Vol. 153, pp. 54-64
Closed Access | Times Cited: 134
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8075-8095
Open Access | Times Cited: 91
Current therapies for actinic keratosis
Caterina Dianzani, Claudio Conforti, Roberta Giuffrida, et al.
International Journal of Dermatology (2020) Vol. 59, Iss. 6, pp. 677-684
Open Access | Times Cited: 84
Current Advances in Hypertrophic Scar and Keloid Management
Natasha Barone, Tyler Safran, Joshua Vorstenbosch, et al.
Seminars in Plastic Surgery (2021) Vol. 35, Iss. 03, pp. 145-152
Open Access | Times Cited: 61
Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases
Kamil Sghier, Maja Mur, Francisco Veiga, et al.
Gels (2024) Vol. 10, Iss. 1, pp. 45-45
Open Access | Times Cited: 15
Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities
Stefano Sol, Fabiana Boncimino, Kristina Todorova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7056-7056
Open Access | Times Cited: 8
Actinic keratosis – review for clinical practice
Erika C. V. de Oliveira, Valéria R. V. da Motta, Paola C. Pantoja, et al.
International Journal of Dermatology (2018) Vol. 58, Iss. 4, pp. 400-407
Closed Access | Times Cited: 81
Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
Solmaz Ohadian Moghadam, Mohammad Reza Nowroozi
Scandinavian Journal of Immunology (2019) Vol. 90, Iss. 6
Open Access | Times Cited: 63
A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions
Laura Del Regno, Silvia Catapano, Alessandro Di Stefani, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 3, pp. 339-352
Open Access | Times Cited: 34
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review
Domenico Arcuri, Brandon Ramchatesingh, François Lagacé, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4989-4989
Open Access | Times Cited: 21
Tumor-associated fibrosis impairs the response to immunotherapy
Angha Naik, Andrew Leask
Matrix Biology (2023) Vol. 119, pp. 125-140
Closed Access | Times Cited: 20
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
Jeff Kamta, Maher Chaar, Anusha Ande, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 57
AIDS-Related Kaposi Sarcoma, Version 2.2019
Erin Reid, Gita Suneja, Richard F. Ambinder, et al.
Journal of the National Comprehensive Cancer Network (2019) Vol. 17, Iss. 2, pp. 171-189
Open Access | Times Cited: 50
Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy
Veronique Beiss, Chenkai Mao, Steven Fiering, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 5, pp. 1573-1585
Open Access | Times Cited: 27
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments
Eliana B. Souto, Raquel da Ana, Vânia Vieira, et al.
Neoplasia (2022) Vol. 30, pp. 100810-100810
Open Access | Times Cited: 27
A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
Humzah Jamshaid, Fakhar ud Din, Maimoona Malik, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
Olivia Chen, Keemberly Kim, Chelsea Steele, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3720-3720
Open Access | Times Cited: 24
Toll-like receptor agonists as cancer vaccine adjuvants
Donghwan Jeon, Ethan C. Hill, Douglas G. McNeel
Human Vaccines & Immunotherapeutics (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
Martina Ghezzi, Silvia Pescina, Andrea Delledonne, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1476-1476
Open Access | Times Cited: 28
Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
Deborah Choe, Dongwon Choi
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top